Borgeson Blake - Insider Transactions
Insider Type
individual
Companies
1
Average
112,343
Total Txns
30
Long-Term
Annual Transaction Insights
| Year | Buy | Sell | Δ | Buy, USD | Sell, USD | Δ |
|---|---|---|---|---|---|---|
| 2023 | 0 | 5 | -5 | 0.00 | 477,769.44 | -477,769.44 |
| 2024 | 0 | 25 | -25 | 0.00 | 2,892,505.89 | -2,892,505.89 |
| Total: | 0 | 30 | 10 | 0.00 | 3,370,275.33 | -3,370,275.33 |
Transactions
| Company | Price | Shares | Total | Published | Completed |
|---|---|---|---|---|---|
| Recursion Pharmaceuticals, Inc. Class A Common Stock US75629V1044 |
7.64 USD |
11,447 Sold |
87,457 USD |
12/11/2024 | 12/11/2024 |
| Recursion Pharmaceuticals, Inc. Class A Common Stock US75629V1044 |
6.72 USD |
11,447 Sold |
76,926 USD |
29/10/2024 | 29/10/2024 |
| Recursion Pharmaceuticals, Inc. Class A Common Stock US75629V1044 |
6.67 USD |
11,447 Sold |
76,326 USD |
15/10/2024 | 15/10/2024 |
| Recursion Pharmaceuticals, Inc. Class A Common Stock US75629V1044 |
6.22 USD |
11,447 Sold |
71,150 USD |
01/10/2024 | 01/10/2024 |
| Recursion Pharmaceuticals, Inc. Class A Common Stock US75629V1044 |
6.84 USD |
11,447 Sold |
78,333 USD |
17/09/2024 | 17/09/2024 |
| Recursion Pharmaceuticals, Inc. Class A Common Stock US75629V1044 |
6.27 USD |
11,447 Sold |
71,718 USD |
03/09/2024 | 03/09/2024 |
| Recursion Pharmaceuticals, Inc. Class A Common Stock US75629V1044 |
7.12 USD |
11,447 Sold |
81,532 USD |
20/08/2024 | 20/08/2024 |
| Recursion Pharmaceuticals, Inc. Class A Common Stock US75629V1044 |
6.82 USD |
11,447 Sold |
78,083 USD |
06/08/2024 | 06/08/2024 |
| Recursion Pharmaceuticals, Inc. Class A Common Stock US75629V1044 |
8.48 USD |
11,447 Sold |
97,041 USD |
23/07/2024 | 23/07/2024 |
| Recursion Pharmaceuticals, Inc. Class A Common Stock US75629V1044 |
7.32 USD |
11,447 Sold |
83,735 USD |
09/07/2024 | 09/07/2024 |